The NCGC pharmaceutical collection: a comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics.
The NCGC pharmaceutical collection: a comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics.
复制标题
DOI:
10.1126/scitranslmed.3001862
复制
发表时间:
2011-04-27
影响因子:
17.1
通讯作者:
Austin CP
中科院分区:
文献类型:
--
作者:
Huang R;Southall N;Wang Y;Yasgar A;Shinn P;Jadhav A;Nguyen DT;Austin CP
Small-molecule compounds approved for use as drugs may be “repurposed” for new indications and studied to determine the mechanisms of their beneficial and adverse effects. A comprehensive collection of all small-molecule drugs approved for human use would be invaluable for systematic repurposing across human diseases, particularly for rare and neglected diseases, for which the cost and time required for development of a new chemical entity are often prohibitive. Previous efforts to build such a comprehensive collection have been limited by the complexities, redundancies, and semantic inconsistencies of drug naming within and among regulatory agencies worldwide; a lack of clear conceptualization of what constitutes a drug; and a lack of access to physical samples. We report here the creation of a definitive, complete, and nonredundant list of all approved molecular entities as a freely available electronic resource and a physical collection of small molecules amenable to high-throughput screening.
登录
查看更多内容
DOI:
10.1038/nrd2030
发表时间:
2006-08
期刊:
Nature reviews. Drug discovery
影响因子:
--
作者:
Ghofrani HA;Osterloh IH;Grimminger F
通讯作者:
Grimminger F
影响因子:
2.2
作者:
DiMasi, Joseph A.;Grabowski, Henry G.
通讯作者:
Grabowski, Henry G.
影响因子:
14.8
作者:
Chong, Curtis R.;Chen, Xiaochun;Sullivan, David J., Jr.
通讯作者:
Sullivan, David J., Jr.
影响因子:
7.3
作者:
Auld, Douglas S.;Southall, Noel T.;Inglese, James
通讯作者:
Inglese, James
DOI:
10.1073/pnas.0604348103
发表时间:
2006-08-01
影响因子:
11.1
作者:
Inglese, James;Auld, Douglas S.;Austin, Christopher P.
通讯作者:
Austin, Christopher P.